FDA approves tildrakizumab for psoriatic arthritis

• by Mouj Hijazi

• October 30, 2026

Combination Therapy Shows Potential in Psoriasis, Obesity

Researchers assess whether adding tirzepatide to ixekizumab affects skin and weight outcomes in adults with moderate to severe plaque psoriasis.

• by Kathryn Wighton

• May 20, 2026

• 5 min

He Needs an Expensive Drug. A Copay Card Helped — Until It Didn’t. - KFF Health News

• by Elisabeth Rosenthal

• February 27, 2026

AI Scribes Lag Clinicians on Note Quality

A VHA study across 11 vendors finds AI-generated primary care notes score lower than clinician-written notes, with the largest deficits in thoroughness, organization, and usefulness

• by Kerri Miller

• April 17, 2026

• 6 min